| Autor: |
Gupta S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA Sgupta21@bwh.harvard.edu.; Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Leaf DE; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA. |
| Abstrakt: |
Competing Interests: Competing interests: Outside of the submitted work, SG reports research support from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases K23DK125672; and research funding from BTG International, GE HealthCare, and AstraZeneca. SG is also a member of GSK’s Global Anemia Council, a consultant for Secretome and Proletariat Therapeutics, and founder and president emeritus of the American Society of Onconephrology (unpaid). DEL is supported by National Institutes of Health grants R01HL144566, R01DK125786, and R01DK126685; reports research support from BioPorto, BTG International, and Metro International Biotech; and has served as a consultant for Sidereal Therapeutics, Casma Therapeutics, and MexBrain. |
